Vertex passes key test in quest to treat kidney diseases
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston. Brian Snyder | Reuters Vertex Pharmaceuticals said its experimental drug for a rare kidney condition succeeded in a Phase 3 trial, a crucial step in the company’s path to diversify beyond its main drugs for cystic fibrosis. The Boston-based drugmaker on…
Read More “Vertex passes key test in quest to treat kidney diseases” »